Guangdong Marubi Biotechnology Co.,Ltd.’s Net Profit Dropped 15.8% in First Three Quarters of 2022

Guangdong Marubi Biotechnology Co.,Ltd. (广东丸美生物技术股份有限公司) (603983.SH) reported a net profit of 115.1 million yuan in the first three quarters of 2022, down 15.8% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 0.5% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 568.5 million yuan in total liabilities, with a liability-to-asset ratio of 15.1%.